Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole for Breast Biomarkers in High Risk Women on HRT
NCT00291135Phase 2Completed
- Start
- Jan 2003
- Primary completion
- Oct 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of letrozole in breast cancer. Primary endpoint: Change in Proliferation of Breast Epithelial Cells Obtained by Random Periareolar Fine Needle Aspiration at 6 months. Started Jan 2003; status: completed.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00291135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00291135.